• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.13% Nasdaq Up0.70%

    More On RPBC

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Redpoint Bio Corporation (RPBC)

    -Other OTC
    0.00 0.00(0.00%) Dec 26, 9:30AM EST
    Add to Portfolio
    ProfileGet Profile for:
    Redpoint Bio Corporation
    Albert Einstein Healthcare Network
    5501 Old York Road
    Philadelphia, PA 19141
    United States - Map
    Phone: 215-456-2312
    Fax: 215-456-7610
    Website: http://www.redpointbio.com

    Details 
    Index Membership:N/A
    Sector:Services
    Industry:Research Services
    Full Time Employees:N/A

    Business Summary 

    Redpoint Bio Corporation, a development stage biotechnology company, focuses on the development of healthier foods and new approaches for the treatment of diabetes and obesity by understanding the biology of taste and its relationship to metabolism, satiety, and diabetes. It enters into a license and commercialization agreement with International Flavors and Fragrances Inc. for the development, manufacture, use, and commercialization of RP44, which is a component of the stevia plant that works as a sweetness enhancer amplifying the existing sugary sweetness in a food or beverage. The company is based in Philadelphia, Pennsylvania.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Redpoint Bio Corporation

    Key Executives 
     PayExercised
    Mr. Scott M. Horvitz , 55
    Interim Chief Exec. Officer, Interim Pres, Chief Financial Officer, Principal Accounting Officer, Treasurer and Sec.
    147.00K0.00
    Dr. Robert F. Margolskee M.D., Ph.D.,
    Founder and Chairman of the Scientific Advisory Board
    N/AN/A
    Mr. Richard C. Lufkin , 67
    Co-founder
    N/AN/A
    Dr. R. Kyle Palmer Ph.D.,
    Sr. Director of Discovery Research
    N/AN/A
    Amounts are as of Dec 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.